Multiomics Approach in Metastatic Clear Renal Cell Carcnoma

Active, not recruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 28, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

September 30, 2027

Conditions
Metastatic Clear Cell Renal Carcinoma
Interventions
RADIATION

CT scan

CT scan at baseline and then every three months as per clinical practice. The standardization of the procedure of images' collection through a CT- acquisition's protocol has been planned to control bias.

BIOLOGICAL

Plasma collection

● Blood samples will be collected at baseline, at 1 month and at the first PD. Sixteen ml of blood will be collected in EDTA tubes and centrifuged at 1900×g for 10 min at 4 °C within 2 h after drawing to collect plasma, which will be stored at -80°C until analysis. Plasma samples will be sent to the Laboratory of Pharmacogenetics - Unit of Clinical Pharmacology and Pharmacogenetics - University Hospital of Pisa. Plasma samples will be used to isolate cell free DNA (cfDNA) and microvesicles-derived RNA for molecular analysis.

Trial Locations (1)

20156

Istituto Tumori, Milan

All Listed Sponsors
lead

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

OTHER